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Bladder cancer (BC) is the 9th cancer cause of death and one of most cost-intensive in the world. The diagnostic
tools are still not at all satisfactory. Herein we evaluated the potential of infrared spectroscopy to detect mo
lecular changes that precede and accompany the carcinogenesis in voided urine sediment. We collected 165
samples from patients being diagnosed for BC and measured them with attenuated total reflectance Fourier
transformed infrared spectroscopy (ATR FTIR). Samples were primarily divided into three groups according to
cytology that indicated the presence of normal, abnormal and cancer cells. ATR FTIR spectra of sediments were
analyzed with the use of partial least square discriminant analysis (PLSDA). The 1800–750 cm− 1 region
discriminated the three groups with selectivity and sensitivity values around 68% using cytology as a reference
method. These cross-validation values (which were found significant according to a permutation test) were
comparable to the sensitivity and specificity values of cytology versus the gold standard (histology). The average
spectra of each class and the regression vectors of the PLS-DA indicated that an increased content of carbohy
drates and nucleic acids as well as transformations of protein secondary structures were the main discriminators
of healthy patients from abnormal and cancer groups. Additionally, we revised the obtained classification ac
cording to diagnosis made on histopathological assessment of bladder sections. We finally discuss the potential of
the technique to be used as a Point of Care (PoC) testing tool.

1. Introduction
Bladder cancer (BC) constitutes significant proportion of human
cancers and has a very high recurrence rate (up to 70% of cases) [1,2].
Urothelial carcinoma (BC, differentiating into urothelium) stands for
about 90% of all bladder malignancies in western countries [3]. The
suspicion of BC arises when a patient has hematuria and BC-positive
family history or is accidentally identified with other lesions in
abdomen by radiology. Currently, diagnostic methods of bladder tumor
include cystoscopy coupled with biopsy and histological examination,
urine cytology, molecular assays, radiological imaging [4–6]. The most
common BC diagnostic methods are still histology and cytology and

immunohistochemistry if needed. Pathologists have to examine many
features of cells and tissues such as architecture of the lesion, an increase
of the cellular layers, cellular atypia, loss of maturation, mitotic activity,
which indicate cancer; however, their interpretation is not always un
equivocal. Furthermore, the biopsy sample might not contain intractable
to find flat malignancy [1,7]. Urine cytology, assessing cells from the
urinary tract, is noninvasive sampling but subjective, time consuming
and limited by low sensitivity (ca. 70 and 30–50% for high (HG)- and
low-grade (LG) carcinoma, respectively) [2,8]. HG bladder carcinoma is
usually identified by the presence of a higher pleomorphism of nuclei,
smaller cells with a higher nuclear to cytoplasmic ratio than in LG BC. It
is relatively easy to distinguish HG BC from normal urothelial cells since
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both show markedly different morphological features like hyper
chromasia, coarseness of nucleoplasm and an irregular shape of nuclei.
LG BC cells are similar to normal urothelium and only few features
discriminate LG BC from normal groups, e.g. reactive changes (enlarged
nuclei, mitoses and nucleoli in BC) and the presence of cells fragments
which mimic tumor debris. The low-grade changes, especially with
papillary morphology, still might be elusive with these properties. Thus,
cytology is rather a good indicator for HG and malignant cases than for
patients with subtle and atypical changes in cell morphology of bladder
[8]. The latter is assigned to the abnormal group whose composition is
very heterogenic making difficult the unequivocal classification of the
patient. Smears do not show the presence of cells morphologically
classified as normal or cancerous ones and contain atypical, but negative
for HG cells, or reactive cells. In addition, the background is not clear
when cell fragments or leukocytes are observed. Beside urothelial cells,
urine also contains matrix and cancer vesicles. Novel genetic and
immunochemical tests detect extracellular vesicles, exosomes, changes
in methylation status, RNA fragments (mRNA, miRNA, tRNA, lncRNA),
circulating tumor and cell-free DNA (ctDNA and cfDNA, respectively) as
well as changes in urinary microbiome, but they are not commonly used
in screening testing due to their high cost [9–11].
This summary of diagnostic methods clearly indicates that there is
still a need for searching alternative, fast, cheap, non-invasive, and
objective technologies supporting the BC diagnosis. Our previous work
on cell lines of BC evidenced that the discrimination and the classifica
tion of BC grade and stage is possible using vibrational spectroscopic
imaging [12]. FTIR (Fourier Transform Infrared) and Raman spectros
copies reveal the chemical composition of a sample due to vibrations of
components and their specific positions and intensities. Any spectral
change proceeds molecular alternation induced by diseases. A potential
applicability of ATR (attenuated total reflection) FTIR technique for BC
classification from filtered bladder wash has been showed by Gok et al.
[13]. In turn, Bensaid and co-workers have employed remote Fiber
Evanescent Wave Spectroscopy (FEWS), which is a combination of ATR
FTIR and fibber sensors, to analyze pre-operative and intra-operative
urine [14]. IR microscopy is also a valuable tool to collect spectra
from single cells. Bird and co-workers have reported IR spectra analyzed
by principal component analysis (PCA) to distinguish healthy glycogenfree and -rich squamous epithelial and urothelial (transitional) epithelial
cells, which are difficult to be recognized in cytology [15]. These works
and FTIR spectroscopic imaging of BC bladder have showed that various
methods of sample collection, preparation, measurements and chemo
metric analysis can be employed to classify urine cells and bladder tissue
fragments [16,17].
Our purpose is to consider the possibility of simply prepared voided
urine sediments to support the BC diagnosis by FTIR spectroscopy. We
intentionally investigated urine sediment, because that is a noninvasive
and simplest method to collect samples containing cancer cells in the
hospital condition. Urine sediment was collected from patients classified
as normal, abnormal and cancer cytology. This classification was
confirmed by histology of bladder sections for cases if it was possible. To
bring the spectroscopic technology to the clinical field in the future, we
selected the simple and rapid ATR FTIR as the best option for collection
of FTIR spectra of urine sediment. Several studies have shown its suit
ability as a Point of Care tool (PoC) tool [18,19], demonstrating that the
technique can be implemented in portable devices to be used in small
clinics or field clinical trials [20], using minimum sample preprocessing
[21], and providing results in a few minutes. In our work we present the
correlation between mid-infrared spectra of urine sediment and routine
cytology to assess if this combination could be an option for the rapid
screening method for BC in a PoC scenario.

Table 1
The size of patient groups diagnosed according to cytology and histology.
Cytological subgroup shows the assignment of 49 patients diagnosed addition
ally by histology to N, A, and C groups according to cytological results. Some
sample exhibited the presence of microhematuria (HU) – hemolysis trace in the
strip test. N – normal, A – abnormal, C – cancer, LG – low grade and HG – high
grade of bladder cancer.

Cytological
groups
Histology
subgroups
Cytological
subgroup

N

N with
HU

A

A with
HU

C

C with
HU

LG/
HG

59

24
(41%)
11
(69%)
8 (62%)

50

56

10

26
(52%)
4 (40%)

27/
29
15/8

11

6 (55%)

25

35
(63%)
17
(74%)
18
(72%)

16
13

23

13/
12

2. Methods
2.1. Collection and preparation of samples with their medical assignment
The study was reviewed and accepted by the First Local Ethical
Committee at the Jagiellonian University Medical College in Krakow
(No. 1072.6120.100.2018).
A total number of urine samples was 165 and these samples were
taken from patients with clinical suspicion of BCa. Average age was 66
years (min = 26; max = 89) and 70% of patients were men. Fresh voided
urine was collected from the patient up to 30 min. after urination and an
urine strip test (One + Step DUS 10, CE certificated) was performed to
estimate the content of leukocytes, nitrite, urobilinogen, protein, pH,
blood, S.G. density, ketones, bilirubin, and glucose. Only some samples
showed the presence of microhematuria (Table 1).
To obtain cytological samples, urine was centrifuged at 2000 RPM
for 5 min, spread with cytospin (Thermo Scientific Cytospin 4), fixed
with 95% ethanol, and finally stained H&E (hematoxylin & eosin).
Cytology was assessed according to the Paris System for Reporting
Urinary Cytology [2] and patients were divided into three groups ac
cording to the presence of normal (N), abnormal (A), and cancer cells
(C). All urine samples did not show in cytology non-urothelial malig
nancies and viral infections, which could interfere the spectroscopic
analysis Bladder wall excisions were taken from 49 patients with unclear
outcomes of cytology and cystoscopy. The histological examination of
the H&E-stained sections was performed according to WHO 2017
guidelines and a grading system recommended by International Society
of Urological Pathology (ISUP) [22]. The size of each patient group with
grading of BC is summarized in Table 1.
Photographic documentation of cytological and histological samples
was recorded using an Olympus BX53 white-light microscope equipped
with an Olympus DP27 digital camera.
2.2. FTIR data acquisition and spectral processing
The remaining fresh urine sediment was fixed with 2% glutaralde
hyde and then centrifuged at 2000 RPM for 5 min. Sediment was washed
with 10 ml distilled water, centrifuged (2000 RPM for 5 min.) and airdried in a desiccator for 48 h. The 2-day delay was caused by prob
lems with the timing of the operators involved on the measurement and
was not necessary in terms of technical requirements of the method.
Such prepared samples were used for ATR FTIR spectroscopic mea
surements with an ALPHA Bruker spectrometer equipped with a 1reflection ATR diamond crystal. Spectra were acquired in the region of
400 – 4000 cm− 1 with a spectral resolution of 4 cm− 1. 128 co-scans were
co-added and an extended ATR correction was applied (using the routine
integrated in the Bruker Opus 7.0 software). For further analysis, the
3100–800 cm− 1 region was selected. ATR FTIR spectra were firstly
vector normalized in the 3100–800 cm− 1 region. Second derivative
(Savitzky – Golay algorithm, 13 smoothing points) and differential FTIR
2

M. Kujdowicz et al.

Microchemical Journal 168 (2021) 106460

Fig. 1. Examples of voided urine cytology of patients from the investigated groups, (A) normal group, (B) abnormal group, and (C) – cancer group and the cor
responding histological stains of bladder wall excisions, (D) normal urothelium, (E) urothelium with dysplasia, and (F) urothelial carcinoma. H&E staining;
magnification: 400x (top) and 200x (bottom).

spectra were calculated and graphed in an Origin 9.1 software (ver.
2018b, OriginLab, OriginLab Corporation, Northampton, MA, USA).
Partial least squares-discriminant analysis (PLSDA) was carried out
with Matlab 2020b from Mathworks (Natick, USA) and the PLStoolbox
from Eigenvector (Manson, USA) functions, by using in-house written

scripts which describe the preprocessing, model selection, validation
and permutation test. The scripts and datasets are available to be
downloaded at the Zenodo repository (https://doi.org//10.5281/
zenodo.4587890).

Fig. 2. Average absorbance and second derivative ATR FTIR spectra (±SD, standard deviation) of urine sediments and their differential spectra. N = 59, A = 50, C =
56 spectra.
3
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3. Results and discussion

Table 2
The most pronounced molecular changes between N, A, C groups (N = 59, A =
50, C = 56) assigned according to cytology. ↓ - decrease, ↑ - increase.

We investigated samples collected from 165 patients suspected
clinically to bladder cancer. Since radiological diagnostics, ultrasonog
raphy and cystoscopy, did not revealed the presence of tumor, cytology
as the best method currently used, was conducted to detect early BC
(Table 1). Urine sediments were investigated spectroscopically as well.
Furthermore, the patients’ conditions were followed up to 6 months
after the urine collection and 49 persons underwent bladder biopsy and
the histological examination. The samples of these patients were redis
tributed in subgroups according both cytology and histology (Table 1).

Biomolecules

Normal

Abnormal

Cancer

Lipids
Proteins
Nucleic acids
Sugars

↓
↓
↓
↑

↑
↑
↑
↓

↑↑
↑↑
↑
↓↓

derivative ATR FTIR spectra, as well as their differential spectra for 165
patients. Band assignment is summarized in Table S2 in SI. Despite
clearly visible differences in the averaged FTIR spectra, their standard
deviation indicates some overlap of the spectral features which very
likely result from cellular heterogeneity in the sediment. The normal
urothelial cells in urine vary in function and morphology due to in
teractions with urine and metabolites. For instance, the basal cells
proliferate to maintain epithelium, whereas the superficial cells from the
upper layers build a barrier. The urine cells from healthy patients might
contain glycogen or not, as it was observed by Bird et al. in FTIR spectra
of single cells obtained from healthy men [15].
Differential IR spectra between C and N, C and A, and A and N groups
calculated from absorbance ATR FTIR spectra indicate the main mo
lecular differences between urine sediment (Fig. 2). Namely, samples
containing BC cells possess more proteins (the 1700–1500 cm− 1 region)
than the sediment with abnormal and normal urothelial cells whereas a
wide region primarily assigned to sugar moieties (1200–900 cm− 1)
shows the absorbance decrease for the cancer and abnormal groups
comparing to N. A slight difference was noted between C and A groups.
Differential spectra calculated for second derivative ATR FTIR spectra
indicate that urine sediment with cancer cells contain more lipids than
the ones with abnormal and normal cells seen in the 3000–2800 cm− 1
region in Fig. 2. Cancer and abnormal cells exhibit large N/C ratio
compared to normal urothelial cells and FTIR spectra follow this feature
as the 1236 and 967 cm− 1 bands of DNA are higher in the spectra of the
former.
The amide I and II region show similar differences to the differential
spectra calculated from the absorbance FTIR traces, but the second de
rivatives indicate pronounced alternations in secondary structures of
proteins. Namely, the C group differs from N group by the high contri
bution of α-helices and unordered conformations whereas the latter
dominates in the abnormal group compared to normal urothelium.
α-Helical conformation is more pronounced in the cancer than in the
abnormal group (Fig. 2). This result suggests that proteins with β-sheet
secondary structure accompany pathological transformation of urothe
lial cells [23]. FTIR bands at 1153, 1078, 1023, and 994 cm− 1 assigned
to glycogen are the highest in the N group and decrease gradually in
abnormal and cancer groups. It is commonly known that many cells
accumulate glycogen or lipids upon stress conditions or the presence of
cancer cells. The urothelial cells, both with normal and cancer
morphology, store carbohydrates like glycogen to synthesize
carbohydrate-lipidic compounds for building glycocalyx and cerebro
side based barrier, which separates the body from urine toxins
[14,16,23–25]. These metabolic changes depend on the molecular
background of urothelial cells and the type of bladder cancer cells
[16,26]. A band assigned to uracil in RNA is progressively shifted from
1109 cm− 1 in N to 1115 cm− 1 in C. These main biocomponent differ
ences between groups are summarized in Table 2.

3.1. Morphological assessment
Cytological H&E stains for each group of patients are summarized in
Fig. 1. Fig. 1A shows urine cytology of the N group with typical uro
thelial cells, i.e. large umbrella cells and medium-sized piriform cells
from superficial and middle layers of urothelium, respectively. Both cells
possess small nuclei and only few leukocytes are found. Fig. 1B and 1C
display cytology of the abnormal and cancer groups, respectively, in
which one can observe large and irregular circumscribed squamous cells
with dark, small, and pin-shaped nuclei. Cytology from a patient with BC
shows the presence of carcinomatous cells with large, irregular-shaped
nuclei with hyperchromatic and coarse chromatin as well as suspi
cious cells, which can be classified as cancer cells (Fig. 1C). Cancer cells
can be assigned to high and low grading of BC. The background is quite
clear and few erythrocytes are present [2,7]. Some cells in the abnormal
group exhibit a higher N/C ratio (nucleus – cytoplasm ratio) than in
normal urothelial cells with a slightly irregular chromatin and nucleoli
assigned to reactive changes (Fig. 1B). The A group comprises samples
with degenerative, therapy-induced and reactive changes, including
inflammation of normal urothelial cells and numerous leukocytes.
Furthermore, atypical urothelial cells are defined when their clear
assignment and morphology is not evident. Table S1 (in SI, Supporting
Information) summarizes morphological features that are considered in
the assignment of the patient to N, A, and C group. They include N/C
ratio, hyperchromasia, irregular nuclear membrane, irregular, coarse
chromatin, pleomorphism, variation of shape and size, prominent
nucleoli, mitoses, necrotic debris, inflammatory cells, and cytoplasmic
homogeneity. Other clinical aspects as infection, radiotherapy and sur
gical procedures history are also important.
The histological examination of bladder biopsies with a diameter of
ca. 3–12 mm relies on the assessment of both cells’ morphology and
architectural tissue re-building. Normal urothelium (epithelium of
bladder) should be composed of less than 5–7 layers of cells (Fig. 1D).
Small cells with a high N/C ratio are localized in layers below the su
perficial one. Singular mitoses are possible in the basal part. Dysplasia is
recognized when the stratification of urothelial cells is lost and the nu
cleus enlargement as well as hyperchromasia and irregular contour is
observed (Fig. 1E, the left part of epithelium). BC without invasion re
sults in remodeling of the cell stratification and nuclei have enlarged and
irregular shape similarly to dysplasia, but carcinoma changes are more
pronounced. Non-invasive BC could be both in situ (flat as in Fig. 1F) or
papillary one when the papilla core contains fibrous tissue with blood
vessels. The invasion means infiltration to basal lamina and further
through the bladder wall to adjacent organs.
3.2. Spectral differences between normal, abnormal and cancer groups
assigned in cytology

3.3. ATR FTIR – Based discrimination of the patient groups

The cytological assessment relies on the examination of single cells
whereas spectroscopic investigations provide information about all cells
in urine sediment. The number of particular cells in a sample may affect
FTIR spectrum, however we decided to not count percentage of all
cancer cells in the sample due to difficulties in their recognition of low
grade bladder carcinoma. Fig. 2 shows average absorbance and second

PLS-DA is a multivariate analysis tool for developing a model to
classify between two groups. In this work, the primary goal was a first
evaluation of the potential of the technique to identify sediment from
patients with BC. However, preliminary studies evidenced that the
presence of A and N samples in the non-cancerous type was a
4
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accuracy of the reference method. Indeed, the sensitivity (SN) and
specificity (SP) of the ATR FTIR based model is limited by the classifi
cation performance of cytology, the method used to label the “y” of the
165 samples of the model. This technique shows a modest accuracy
when compared with histological examination, the gold standard
method for BC diagnosis. Here, SN and SP are max. 70 and 90%,
respectively, for HG BC while SN decreases up to 30% for abnormal cells
and LG BC. As accuracy, sensitivity and specificity calculated for FTIR
spectral classification are 60 – 70% regardless the level of cellular ab
normality, this simple, label-free and rapid method for the investigations
of urine sediment shows the high capability to support the diagnosis of
BC.
Fig. 3 displays regression vectors for each 2-group discrimination
gathered PLS-DA with receiver operation curves (ROC). In the latter, the
x-axis shows false positive rates (1-specificity) and the y-axis represents
true positive rates (sensitivity). In turn, the area under the ROC curve
(AUC) summarizes the overall performance of the ATR FTIR screening of
urine sediment. From the leave-one-out cross validation, the AUC values
are 0.74 (N vs. C), 0.63 (A vs. C), and 0.61 (A vs. N) indicating a good
prediction capability, however it worsens for the abnormal cells (Fig. 3
B). Once again, we must stress here that the test method cannot provide
a better performance than a the reference method to which we refer our
classification.
Finally, the PLSDA models were investigated to find spectral markers
responsible of the discriminations. The regression vectors of the three
models are shown in Fig. 3 A. In the case of the models created using the
FD, the regression vector was integrated using the function cumsum in
Matlab. Most of them well correspond to spectral markers of the groups
found in the differential FTIR spectra discussed above. In the PLS DA
model for the normal versus cancer groups, positive signals of proteins
and DNA at 1640/1545/1455 and 1238 cm− 1, respectively assigned to
the C groups are localized at) whereas strong minima in the region of
1200 – 900 cm− 1 attributed to glycogen are specific for the normal
group. Regression vectors for the abnormal and cancer group depict the
presence of signals at 1368, 1270, 1100, 967 cm− 1 assigned to some of
carbohydrates, purines and DNA bands for C and the shift of amide I and
II bands toward A. In turn vectors for the A and N pair suggests that a set
of peaks assigned to lipids, carbohydrates, and RNA (1718, 1590, 1540,
1490, 1400, 1315, 1140, 1090 1070, 960 cm− 1) are specific for in
flammatory and atypical cells. The fact that glycogen bands are impor
tant for the N vs. C classification in contrast to the other group

Table 3
Confusion matrices from the PLS DA classification of ATR FTIR spectra between
C and N, C and A, and A and N groups and referred to the cytological assignment.
CCR – accuracy, SN – sensitivity, SP – specificity, TP – true positive, FP – false
positive, FN – false negative, TN – true negative. *P-value obtained from the
permutation test. **Preprocessing used: Mean Centering (MC), Standard Normal
Variate (SNV), Extended Multiplicative Standard Correction (EMSC) and First
derivative (FD). ***Number of Latent Variables.
C versus N
(CCR = 68%, SN = 68%, SP = 68%, p-value*=0.01)
ATR FTIR classification; [SNV, FD, MC]**; 2***
C versus A
(CCR = 64%, SN = 66%, SP = 63%, p-value*=0.03)
ATR FTIR classification; [EMSC, FD, MC]**; 8***
A versus N
(CCR = 64%, SN = 70%, SP = 60%, p-value*=0.01)
ATR FTIR classification; [SNV, FD, MC]**; 9***

Cytological
C: 56
TP: 38
FN: 18
Cytological
A: 50
TP: 33
FN: 17
Cytological
A: 50
TP: 35

classification
N: 59
FP: 19
TN: 40
classification
C: 56
FP: 21
TN: 35
classification
N: 59
FP: 24

confounding factor which hampered significantly the discrimination.
Thus, we investigated spectral markers characteristics of each group as
well as to assess the discrimination level between N and C, A and C, A
and N groups. From the total ATR FTIR spectra of 165 samples, the size
of each was subgroup was limited (less than60 samples) and thus, it was
impossible to create independent and representative calibration and test
sets.
The fingerprint region (1800–750 cm− 1) was considered for the
modelling. The number of latent variables were chosen from a maximum
of 10. The combination of different preprocessing was used, namely
Standard normal variate (SNV) normalization, extended multiplicative
scattering correction (EMSC) using the average spectrum of the dataset
as the reference spectrum, a 15 smoothing points Savitzky – Golay first
derivative (FD) and mean center. We then employed cross-validation
(CV) as a measure of the classification performance of each model and
investigated the regression vector for potential spectral markers. As CV
error can provide over-optimistic results, we used a permutation test to
ensure that the errors obtained were statistically significant.
Table 3 presents confusion matrices and their parameters obtained in
the PLS DA model based on cytological classification of 165 cases. In
general, classification errors range between 64 and 68%. All the errors
were found significantly different by the permutation test (Wilcoxon)
with p-values below 0.03 and should be put in the context of the

Fig. 3. Graphical results of PLS DA for the N, A, and C diagnosis. A present the cumulative sums of the regression vector of the discrimination (‘+’ – positive value of
vector for marked group) and B show the receiver operation curves (ROC) for the cross validation of the patient groups.
5
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Fig. 4. Average absorbance and second derivative ATR FTIR spectra (±SD, standard deviation) of urine sediments and their differential spectra for the histologically
and cytologically assigned subgroups (in Table 1). NH = 16, AH = 10, CH = 23; NC = 13, AC = 11, CC = 25.

combinations results from the ratio of healthy and cancerous cells and
the number of cells exfoliated from bladder. Among BC cells high grade
BC is recognized with 70% sensitivity in cytology and thus the glycogen
decrease in FTIR spectra can additionally confirm a higher risk of HG BC.
For the discrimination of the A and C groups, increasing absorbance of
the DNA bands is in concordance with a higher N/C ratio in atypical and
cancer cells resulting from a high mitotic rate and multiploidy in that
cells [7]. The question arises if the strong contribution of glycogen to the
discrimination of all investigated groups does not result from diabetes
mellitus (DM) or low pH of urine (below 3.5) [27]. But none of the
patients in our groups was diagnosed for DM and pH of urine is found in
the normal range, i.e. N: 5.50 (±0.58); A: 5.25 (±1.04), and C: 5.41
(±0.65).
In the cytological diagnosis of BC patients, the main purpose is to
recognize all cancer cases and their overdiagnosis is a minor issue. In
suspected cases, the urologist conducts cystoscopy and eventually bi
opsy. Among 165 cases investigated by us, 49 patients were again
diagnosed with histology (histological subgroup in Table 1). We track all
samples misclassified by the ATR FTIR - PLS DA approach in the histo
logical verification. Among 23 CH cases, 5 and only 1 patients are false
negative according to cytology and ATR FTIR spectroscopy, respec
tively. Whilst 16 NH cases (true negative) were first cytologically clas
sified as 4 NC, 6 AC, and 6 CC. In consequence, 75% patients underwent
further unnecessary diagnostics. In turn, FTIR spectra of the sediments
in this group are assigned to 7 N, 5 A, and 4C cases. Finally, among 10 AH

patients, cytology did not show any abnormalities in 4cases whereas
FTIR spectra assigned only 1 case to the normal group. This suggests that
the combination of cytological and spectroscopic assignment could
revise the final classification of the patient. We also note that the FTIRbased classification model should rely on the two-step verification - C vs.
N and A vs. N to detect all cancer and premalignant changes.
3.4. Spectral differences between histological and cytological subgroups
If FTIR spectra assignment of the patients to C, A, and N groups
shows a better agreement with the histological than cytological classi
fication, the averaged spectral profiles of the groups probably differ
between themselves. The two classification methods rely on the recog
nition of different cancer features, i.e. cytology is based on cell
morphology whereas histology includes both cellular morphology and
their arrangement in the bladder wall). Thus, the cytological examina
tion often misclassifies LG BC and well detects HG BC, whereas histology
is similarly sensitive to both groups of bladder carcinoma. We compare
ATR FTIR spectra of the cytological and histological subgroups in Fig. 4,
see also Table 1. The main spectral differences are observed in the
spectral regions specific for glycogen, proteins, and lipids and exhibited
as main discriminator on PLS DA, see differential spectra calculated
from absorbance ATR FTIR spectra in Fig. 4 and regression vectors in
Fig. 3. The CH subgroup contains more carbohydrates and lipids and less
proteins than CC on contrary to NH and NC. The AH and AC subgroups
6
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urine. However, no spectral differences in the secondary structures of
proteins (the region of amide I band) on contrary to A and C groups
suggest that the overall spectral profile of the urine can contribute to the
grading classification.
HG bladder carcinoma is known to be more aggressive than LG.
Because the histological examination of the investigated groups allows
for classification of BC according to its invasiveness, we compare finally
ATR FTIR spectra of urine sediments of non– and invasive carcinoma
(Fig. S1 in SI). They indicate again that the higher glycogen and lipid
content is specific for the non-aggressive and non-invasive BC. But the
protein characteristics is different from the LG – HG BC groups.

Table 4
Spectral features of the histological normal, abnormal, and cancer subgroups in
comparison to cytology. ↓ - decreased, ↑ - increased, → - down-shift, ← - up-shift.
Band [cm− 1]

Normal

Abnormal

Cancer

2923, 2852
1715–1700
1680
1650
1640
1623
1202, 1078, 994
1153, 1023
1052
944, 857

↓
↓
↓
↑
↑
↓
↓
↓
→ (7 cm− 1) ↑

↑
↓
–
↓
↑
–
–
↓
→ (7 cm− 1) and ↑
–

→ (4 cm− 1)
↑
↑
–
↓
–
↑
–
← (4 cm− 1) and ↑
–

3.6. Evaluation of the technique as a Point of Care tool

reveal the decrease of the sugar level with the increase of the protein
content when the histological assessment is taken into consideration.
The second derivative FTIR spectra and their difference indicate addi
tionally specific bands which contribute to the observed variances be
tween the cytological and histological subgroups (Table 4).

Although ATR-FTIR shows great potential for the PoC testing of BC,
there are several challenges that should be overcome to implement the
technique in the context of a community clinic, pharmacy or the doctoŕs
office. The main impediment is the turnaround time (TAT), i.e. the timelapse between the test and the application of the clinical treatment or
response. The measurement of the spectra is performed in less than 5
min, and the computation of the result by the model from an unknown
sample takes less than a second. However, the sample preprocessing
involving the fixation and drying of the sample can delay the result of
the test. In this regard, the drying of the samples could be easily short
ened using air and heat systems. The steps of centrifugation and fixation
and cleaning steps are more problematic, requiring moderate qualified
staff as well as the use and disposal of reagents. These requirements may
be available at some PoC locations, but limits its use on the patientś

3.5. Spectral differences between low and high grade bladder cancer.
We mentioned above about the issue with the cytological recognition
of low-grade bladder carcinoma. For this purpose, we compare ATR
FTIR spectra of LG BC with HG BC to assess to what degree their spectral
discrimination is possible. Absorbance FTIR spectra clearly show an
increase of absorbances in the lipid- and carbohydrate-region, i.e. 2959
–2852 cm− 1 and 1153 – 967 cm− 1 in LG BC (Fig. 5.). Since these features
are specific for the abnormal group as well, ATR FTIR-based classifica
tion of LG BC might be obscured by the presence of atypical cells in

home. Although the method is not far away from the PoC scenario,
future efforts should focus on implementing microfluidics strategies to

Fig. 5. Averaged absorbance and second derivative ATR FTIR spectra (±SD, standard deviation) of urine sediments and their differential spectra for low- (LG C) and
high grade (HG C) bladder cancer. LG = 27, HG = 29.
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4. Conclusions
In this work we proposed that ATR FTIR spectra of the urine sedi
ment are useful for the support of the BC diagnosis. The simple urine
sediment preparation and rapid and label free data collection provided
the spectral markers contributing to discrimination of normal, atypical
and cancer urothelial cells. The main spectral differences between the
investigated groups were found in the spectral regions of glycogen,
proteins and lipids. Based on that PLS-DA classification was satisfied and
comparable with the cytological assessment. We pointed out that the
choice of the gold reference method is crucial for the evaluation of
sensitivity and specificity of the spectroscopic approach. This was re
flected in the proper FTIR based re-assignment of cancer-suspected pa
tients when they were additionally diagnosed by histology of the
bladder excisions. Although the histologic diagnosis of papillary bladder
carcinoma is not usually difficult for a qualified pathologist, the urine
cytology is more problematic. The standard Paris criteria are focused on
identifying life-threatening high-grade tumors, whereas much more
frequent low-grade cancer shows minimal abnormalities at the cellular
level and is very difficult to be distinguished from normal urothelial cell.
The analyzed ATR FTIR spectra of the LG, HG and invasive BC suggested
that the recognition of these groups is also possible. Considering the
challenge of having a reference method with limited accuracy, future
works should aim to perform the models using as the gold standard
histology as a ground true. Further FTIR study on large group of patients
diagnosed histologically could prove this hypothesis suggested by our
preliminary results.
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